Diarrhea in solid organ transplant recipients

被引:35
作者
Angarone, Michael [1 ]
Ison, Michael G. [1 ,2 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Div Organ Transplantat, Chicago, IL 60611 USA
关键词
CLOSTRIDIUM-DIFFICILE INFECTION; CHRONIC NOROVIRUS INFECTION; SINGLE-CENTER EXPERIENCE; VERSUS-HOST-DISEASE; QUALITY-OF-LIFE; GASTROINTESTINAL COMPLICATIONS; IMMUNOCOMPROMISED PATIENTS; MYCOPHENOLATE-MOFETIL; UNITED-STATES; RISK-FACTORS;
D O I
10.1097/QCO.0000000000000172
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of review Diarrhea is a common complaint in the solid organ transplant recipient. Unlike the immune-competent patient, diarrhea in an organ transplant recipient may result in dehydration, increased toxicity of medications, and rejection. There is a wide range of causes for diarrhea in transplant recipients, but the most common causes are Clostridium difficile infection, cytomegalovirus, and norovirus. This review will focus on new epidemiology data as to the cause of diarrhea in the transplant population. Recent findings Recent data have identified C. difficile, cytomegalovirus, and norovirus as important causes of diarrhea in this population, and management should be focused on these causes. Newer diagnostic platforms (such as PCR) are being evaluated, which may help in identification of the cause of diarrhea. New epidemiologic data and new testing techniques offer an opportunity for research into better testing strategies for transplant patients with diarrhea. These newer testing strategies may offer better insight into the cause of diarrhea and more appropriate treatment for this illness.
引用
收藏
页码:308 / 316
页数:9
相关论文
共 81 条
[1]   Patterns of Injury in Mycophenolate Mofetil-Related Colitis [J].
Al-Absi, A. I. ;
Cooke, C. R. ;
Wall, B. M. ;
Sylvestre, P. ;
Ismail, M. K. ;
Mya, M. .
TRANSPLANTATION PROCEEDINGS, 2010, 42 (09) :3591-3593
[2]   PROSPECTIVE COMPARISON OF DIRECT IMMUNOFLUORESCENCE AND CONVENTIONAL STAINING METHODS FOR DETECTION OF GIARDIA AND CRYPTOSPORIDIUM SPP IN HUMAN FECAL SPECIMENS [J].
ALLES, AJ ;
WALDRON, MA ;
SIERRA, LS ;
MATTIA, AR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (06) :1632-1634
[3]  
[Anonymous], J AM MED ASS
[4]   Etiologic agents of diarrhea in solid organ recipients [J].
Arslan, H. ;
Inci, E. K. ;
Azap, O. K. ;
Karakayali, H. ;
Torgay, A. ;
Haberal, M. .
TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (04) :270-275
[5]   Norovirus in Immunocompromised Patients [J].
Atmar, Jill ;
Mullen, Ellen .
ONCOLOGY NURSING FORUM, 2013, 40 (05) :434-436
[6]   Adverse gastrointestinal effects of mycophenolate mofetil - Aetiology, incidence and management [J].
Behrend, M .
DRUG SAFETY, 2001, 24 (09) :645-663
[7]   Cryptosporidium infection after renal transplantation in an endemic area [J].
Bhadauria, D. ;
Goel, A. ;
Kaul, A. ;
Sharma, R. K. ;
Gupta, A. ;
Ruhela, V. ;
Gupta, A. ;
Vardhan, H. ;
Prasad, N. .
TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (01) :48-55
[8]   Gastrointestinal infections caused by cytomegalovirus [J].
David A. Bobak .
Current Infectious Disease Reports, 2003, 5 (2) :101-107
[9]   Norovirus Gastroenteritis in Immunocompromised Patients [J].
Bok, Karin ;
Green, Kim Y. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (22) :2126-2132
[10]   Cryptosporidium enteritis in solid organ transplant recipients: multicenter retrospective evaluation of 10 cases reveals an association with elevated tacrolimus concentrations [J].
Bonatti, H. ;
Barroso, L. F., II ;
Sawyer, R. G. ;
Kotton, C. N. ;
Sifri, C. D. .
TRANSPLANT INFECTIOUS DISEASE, 2012, 14 (06) :635-648